Latest stories on ENGN
enGene Therapeutics: Slashing Cash Burn To Bring Their Asset To The Market
Seeking Alpha63 · neutralproduct/pr
Engene Holdings stock rating maintained at Market Perform by Citizens
Investing.com Analyst Ratings50 · neutralanalyst
enGene reports Q3 EPS (47c), consensus (43c)
The Fly52 · neutralearnings
enGene Holdings GAAP EPS of -$0.47 misses by $0.04
Seeking Alpha34 · bearishearnings
enGene Reports Third Quarter 2026 Financial Results and Provides Business Update
StockTitan56 · neutralearnings
EnGene to Spotlight Bladder Cancer Gene Therapy at Major Investor Conferences
TipRanks65 · bullishproduct/pr
enGene to Participate in Upcoming Investor Conferences
StockTitan56 · neutralgeneral
Engine Media Holdings trading halted, news pending
The Fly50 · neutralgeneral
enGene Highlights Progress of Lead Bladder Cancer Therapy
TipRanks65 · bullishproduct/pr
enGene Holdings appoints new chairman to guide growth
TipRanks56 · neutralgeneral
enGene Focuses Board to Support Planned Upcoming Regulatory and Commercial Milestones | ENGN Stock News
StockTitan63 · neutralproduct/pr
Envision Greenwise Swings to Profit on Revenue Surge and Resumes Dividend
TipRanks73 · bullishearnings
Neumora depression drug fails; EnGene to cut 50% of staff
Yahoo Finance28 · bearishgeneral
enGene Holdings GAAP EPS of $0.43
Seeking Alpha50 · neutralearnings
enGene Restructures, Cuts Workforce to Advance Bladder Therapy
TipRanks34 · bearishgeneral
enGene Reports Second Quarter 2026 Financial Results and Provides Business Update | ENGN Stock News
StockTitan34 · bearishearnings
enGene Therapeutics Inc. (ENGNW) files 8-K
SEC 8-K50 · neutralgeneral
ENGN Investors Have Opportunity to Join enGene Therapeutics Inc. Fraud Investigation with the Schall Law Firm
Morningstar50 · neutralgeneral
EnGene Therapeutics: The Selloff Creates An Opportunity
Seeking Alpha58 · neutralgeneral
ENGN Investors Have Opportunity to Join enGene Therapeutics Inc. Fraud Investigation with the Schall Law Firm
Morningstar34 · bearishgeneral